KCNK2 anticorps (AA 4-14)
Aperçu rapide pour KCNK2 anticorps (AA 4-14) (ABIN5540445)
Antigène
Voir toutes KCNK2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 4-14
-
Séquence
- SASRERPGYT A
-
Specificité
- This antibody reacts with the 47 kDa TREK-1 in Jurkat cell extract.
-
Purification
- Protein G affinity
-
Immunogène
- A synthetic peptide derived from the amino sequence 4-14 of human TREK-1, conjugated with KLH
-
-
-
-
Indications d'application
- ELISA: The antibody (1:500,000 diluted) can detect the TREK-1 peptide coated on ELISA plate at 100 ng/well. Western blot: Dilute approx. 1:3,000 to detect the 47 kDa TREK-1 in Jurkat cell extract.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 0.01M PBS, pH 7.4
-
Agent conservateur
- Azide free
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store lyophilized at 2-8°C for 6 month or at -20°C long term. After reconstitution store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C long term. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Date de péremption
- 12 months
-
-
- KCNK2 (Potassium Channel, Subfamily K, Member 2 (KCNK2))
-
Autre désignation
- kcnk2
-
Sujet
- TWIK-related potassium channel 1(TREK-1), also known as K2P2.1, is a two pore domain gated potassium channel that is involved with pain reception. TREK-1 is highly expressed in small sensory neurons and is extensively colocalized with TRPV1. TREK-1 is sensitive to noxious stimuli including extracellular pH , temperature, mechanical force, osmotic pressure and other stimuli. TREK-1 is one of the targets for pain mediator and anaesthesia drug.
Antigène
-